InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (11 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
11
T+90 hit rate
40%
T+90 mean return
-1.5%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by FOLETTA MARK G, Director. Officer active across 2 companies, notably DEXCOM INC. In total, 25 disclosures have been logged. Split: 1 buy · 11 sells. Total volume traded: €1.1m. History available since 20 May 2021. The latest transaction was filed on 28 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations25 total
6,331 shares0Common StockSEC:0001093557-26-000122:0
2,973 shares0Common StockSEC:0001093557-25-000149:0
3,019 shares0Common StockSEC:0001142750-25-000017:0
7 shares@ US$115.180.6% of flowCommon StockSEC:0001093557-24-000133:0
2,973 shares0Common StockSEC:0001093557-24-000116:0
3,306 shares0Common StockSEC:0001093557-24-000095:0
1,681 shares0Common StockSEC:0001142750-24-000032:0
500 shares@ US$56.902.9% of flowCommon StockSEC:0001142750-24-000024:0
Ideal exit: 25 Nov 2024 (T+270)
3,306 shares@ US$0.0010.0% of flowCommon StockSEC:0001093557-23-000139:0
1,458 shares0Common StockSEC:0001209191-23-025606:0
1,458 shares@ US$88.7812.8% of flowCommon StockSEC:0001209191-23-025606:1
4,989 shares@ US$84.2941.9% of flowCommon StockSEC:0001209191-23-024223:0
300 shares0Common StockSEC:0001209191-22-061721:0
1,054 shares0Common StockSEC:0001093557-22-000117:0
2,139 shares0Common StockSEC:0001209191-22-025451:0
41 shares@ US$556.8915.2% of flowCommon StockSEC:0001093557-21-000270
41 shares@ US$556.890.0001% mcap15.3% of flowCommon StockSEC:0001093557-21-000270:0
45 shares@ US$615.130.0001% mcap18.2% of flowCommon StockSEC:0001093557-21-000251:0
45 shares@ US$615.1318.1% of flowCommon StockSEC:0001093557-21-000251
47 shares@ US$538.020.0001% mcap16.6% of flowCommon StockSEC:0001093557-21-000235:0
47 shares@ US$538.0216.5% of flowCommon StockSEC:0001093557-21-000235
2,500 shares@ US$95.0160.032% mcap50.0% of flowCommon StockSEC:0001209191-21-040544:0
2,500 shares@ US$95.01621.2% of flowCommon StockSEC:0001209191-21-040544
895 shares0Common StockSEC:0001093557-21-000138:0
895 shares0Common StockSEC:0001093557-21-000138
25 of 25 declarations
About FOLETTA MARK G
Mark G. Folette is a Director at Dexcom Inc and AMN Healthcare Services Inc. He plays a key role in corporate governance and strategic decision-making. His expertise is essential for guiding the companies' initiatives.
